Postmenopausal Osteoporosis: Fracture Risk and Prevention

October 1, 2009|OBG Management
This Manuscript;Associated Publication Costs;Including Honoraria For The Authors;Were Funded Amgen.
Author and Disclosure Information

 

Co-Chairs

ANDREW M. KAUNITZ, MD
Professor and Associate Chair
Department of Obstetrics and Gynecology
University of Florida College of Medicine–Jacksonville
Jacksonville, Florida

MICHAEL R. McCLUNG, MD
Director, Oregon Osteoporosis Center
Portland, Oregon

Faculty

ROBERT G. FELDMAN, MD
Medical Director
Senior Clinical Trials, Inc.
Private Practice
Laguna Hills, California

SUSAN WYSOCKI, RNC, NP, FAANP
President and CEO
National Association of Nurse Practitioners in Women’s Health
Washington, DC

This monograph reviews advances in our understanding of the pathophysiology of postmenopausal osteoporosis and new recommendations for best practices in diagnosis and treatment. In Part 1, bone expert Michael R. McClung, MD, comments on new findings concerning bone metabolism. In Part 2, health care providers discuss how to identify and manage postmenopausal osteoporosis patients at risk for fracture.

,false